The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Have You Heard

Sunday, 13 August 2017
A new blueprint for diabetes care has been published by NHS England in a bid to improve and reduce variation of care.
Category: Have You Heard
Topics covered:
Sunday, 13 August 2017
An innovative change programme created by Diabetes UK and Ashridge Executive Education, in collaboration with Novo Nordisk who are providing support and funding, has been awarded the prestigious EFMD Excellence in Practice Gold award. The Diabetes UK Clinical Champions programme has been designed to help health professionals in the NHS to tackle failings and complex challenges in diabetes healthcare.
Category: Have You Heard
Topics covered:
Sunday, 13 August 2017
The European Commission has approved patiromer (Veltassa®) for the treatment of hyperkalaemia, which marks the first new drug licenced specifically for the treatment of hyperkalaemia in over 60 years.
Category: Have You Heard
Topics covered:
Monday, 17 July 2017
Arrhythmia Alliance, in collaboration with Happitech and Bug Labs, have launched the Heart for Heart e-health initiative where people can contribute their heart rhythm data using the free Heart for Heart iPhone app.
Category: Have You Heard
Topics covered:
Monday, 17 July 2017
A new series of 40 films on heart failure have been released by the Sound Doctor, a leading provider of health-related film and audio content for patients. The films are released in partnership with Guy’s and St Thomas’ NHS Foundation Trust and Kings College Hospital NHS Trust, and have been produced with input from the British Heart Foundation (BHF).
Category: Have You Heard
Topics covered:
Monday, 17 July 2017
Management of type 2 diabetes continues to be very challenging. Adherence with therapy is poor, due in part to the number of medications and the high frequency they need to be taken each day. PillTime is a new system which makes managing medicines easier and is ideal for those on multiple medicines and active lifestyles.
Category: Have You Heard
Topics covered:
Wednesday, 07 June 2017
NICE have recently updated the guidance in a number of sections of the type 2 diabetes guidelines (NG28). New information on sodium–glucose cotransporter 2 (SGLT-2) inhibitors has been added to the section on initial drug treatment when metformin is contraindicated or not tolerated.
Category: Have You Heard
Topics covered:
Wednesday, 07 June 2017
A new survey from the Atrial Fibrillation society shows a high level of demand for self-monitoring in people being treated with warfarin. In the survey, 79% of respondents said that they would prefer to self-monitor over clinic visits. New self- monitoring products are being launched.
Category: Have You Heard
Page 2 of 3

Article search and filter